Tag

Cronos Group Inc

• Cronos Group enters the Swiss medical cannabis sector
  Rowan Dunne · Jul 4, 2025
• Schmidt retires, Cronos welcomes back Gorenstein as CEO
  Nick Laba · Mar 21, 2022
• Cronos reports US$134M Q4 net loss on closing of Peace Naturals facility
  Nick Laba · Mar 1, 2022
• Cronos releases delayed Q3 results, adds US$236.1M impairment charge
  Nick Laba · Feb 18, 2022
• Cronos continues to tumble after receiving Nasdaq delinquency letter
  Nick Laba · Nov 23, 2021
• Cronos continues cash burn with US$161M loss in Q1
  Jared Gnam · May 7, 2021
• Organigram shares surge on big tobacco deal
  Jared Gnam · Mar 11, 2021
• Cronos stock drops on US$111.7M Q4 loss
  Jared Gnam · Feb 27, 2021
• Cronos stock pops despite rising losses
  Jared Gnam · Nov 6, 2020
• Croptober 2020: Why a tsunami of Canadian outdoor will go up in smoke
  Jared Gnam · Oct 20, 2020
• Crumbling Cronos enlists CPG CEO
  Nick Laba · Sep 10, 2020
• Amyris scales production of its first yeast-created cannabinoid
  Nick Laba · Sep 1, 2020
• Cronos stock craters on weak Canadian weed sales and US$107M loss
  Jared Gnam · Aug 7, 2020
• Cronos continues to underwhelm in Q1, warns COVID-19 will hamper sales
  Jared Gnam · May 9, 2020
• CBD beauty market worth nearly US$1 billion by 2024: report
  Jared Gnam · Jan 25, 2020
• Investors hold their breath as Tilray, Cronos lead cannabis earnings week with mixed results
  Jared Gnam · Nov 14, 2019
• Market Capitalization Shrinks by $33.18 Billion For Top 10 Canadian Cannabis Companies Since Legalization
  Michelle Gamage · Oct 10, 2019